Published on India Environment Portal | News, reports, documents, blogs, data, analysis on environment & development | India, South Asia (http://admin.indiaenvironmentportal.org.in)

Home > Reports and Documents > WHO interim guidance on the use of bedaquiline to treat MDR-TB > WHO interim guidance on the use of bedaquiline to treat MDR-TB

WHO interim guidance on the use of bedaquiline to treat MDR-TB [1]

WHO estimates that up to half a million new cases of multidrug-resistant tuberculosis (MDR-TB) occur worldwide, each year. Current treatment regimens for MDR-TB present many challenges: treatment lasts 20 months or more, requiring daily administration of drugs that are more toxic, less effective, and far more expensive than those used to treat drug-susceptible TB. Globally, less than half of all patients who start MDR-TB therapy are treated successfully.

Publication Date: 
13/06/2013
WHO [2]
Tags:
Tuberculosis [3], Drugs [4], WHO [5], Health Policy [6]

Technology Partners: MimirTech

Source URL: http://admin.indiaenvironmentportal.org.in/reports-documents/who-interim-guidance-use-bedaquiline-treat-mdr-tb

Links:
[1] http://admin.indiaenvironmentportal.org.in/reports-documents/who-interim-guidance-use-bedaquiline-treat-mdr-tb
[2] http://admin.indiaenvironmentportal.org.in/category/publisher/who
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/tuberculosis
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drugs
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/who
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health-policy